Roberto Silva, Isabel Brandão, Tony J Chen, Hans-Peter Marti, Bárbara Gomes, Bernardo Faria, Manuel Pestana, Jorge R Almeida, Inês S Alencastre, João Paulo Oliveira
{"title":"Peroxidasin expression patterns predict fibrosis and kidney function decline in IgA nephropathy.","authors":"Roberto Silva, Isabel Brandão, Tony J Chen, Hans-Peter Marti, Bárbara Gomes, Bernardo Faria, Manuel Pestana, Jorge R Almeida, Inês S Alencastre, João Paulo Oliveira","doi":"10.1007/s10157-026-02912-y","DOIUrl":null,"url":null,"abstract":"<p><p>Peroxidasin (PXDN), a heme-containing peroxidase involved in basement membrane assembly, has been increasingly implicated in fibrotic processes, yet its role in kidney disease remains unclear. We therefore characterized PXDN expression in kidney biopsies from patients with IgA nephropathy (IgAN), a leading cause of CKD, and assessed its association with fibrosis. Immunofluorescence demonstrated widespread PXDN expression across renal compartments, with predominant localization in distal tubules, consistent with healthy tissue. In contrast, PXDN expression was reduced in proximal tubules, including non-atrophic segments, and markedly increased in the fibrotic interstitium. PXDN strongly correlated with collagen III deposition in sclerotic glomeruli and fibrotic interstitium, but not with collagen IV. Clinically, patients with impaired kidney function (eGFR < 60 ml/min/1.73 m²) exhibited higher PXDN expression in glomeruli, proximal tubules, and fibrotic interstitium, with glomerular PXDN inversely correlating with eGFR. These findings reveal compartment-specific alterations in PXDN expression in IgAN, associated with interstitial fibrosis, collagen III deposition, and declining kidney function. PXDN may participate in fibrotic remodeling processes and represents a potential therapeutic target, warranting further investigation in CKD progression.</p>","PeriodicalId":10349,"journal":{"name":"Clinical and Experimental Nephrology","volume":" ","pages":"1547-1558"},"PeriodicalIF":2.4000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13669128/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10157-026-02912-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/27 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Peroxidasin (PXDN), a heme-containing peroxidase involved in basement membrane assembly, has been increasingly implicated in fibrotic processes, yet its role in kidney disease remains unclear. We therefore characterized PXDN expression in kidney biopsies from patients with IgA nephropathy (IgAN), a leading cause of CKD, and assessed its association with fibrosis. Immunofluorescence demonstrated widespread PXDN expression across renal compartments, with predominant localization in distal tubules, consistent with healthy tissue. In contrast, PXDN expression was reduced in proximal tubules, including non-atrophic segments, and markedly increased in the fibrotic interstitium. PXDN strongly correlated with collagen III deposition in sclerotic glomeruli and fibrotic interstitium, but not with collagen IV. Clinically, patients with impaired kidney function (eGFR < 60 ml/min/1.73 m²) exhibited higher PXDN expression in glomeruli, proximal tubules, and fibrotic interstitium, with glomerular PXDN inversely correlating with eGFR. These findings reveal compartment-specific alterations in PXDN expression in IgAN, associated with interstitial fibrosis, collagen III deposition, and declining kidney function. PXDN may participate in fibrotic remodeling processes and represents a potential therapeutic target, warranting further investigation in CKD progression.
期刊介绍:
Clinical and Experimental Nephrology is a peer-reviewed monthly journal, officially published by the Japanese Society of Nephrology (JSN) to provide an international forum for the discussion of research and issues relating to the study of nephrology. Out of respect for the founders of the JSN, the title of this journal uses the term “nephrology,” a word created and brought into use with the establishment of the JSN (Japanese Journal of Nephrology, Vol. 2, No. 1, 1960). The journal publishes articles on all aspects of nephrology, including basic, experimental, and clinical research, so as to share the latest research findings and ideas not only with members of the JSN, but with all researchers who wish to contribute to a better understanding of recent advances in nephrology. The journal is unique in that it introduces to an international readership original reports from Japan and also the clinical standards discussed and agreed by JSN.